ArticleTurkish journal of medical sciences2025
A comparison of TURP, HoLEP, and RFA for nonneurogenic LUTS in men.
Article in Turkish journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: The effect of transurethral resection of the prostate (TURP) for nonneurogenic male lower urinary tract symptoms (LUTS) is well known. However, recent advancements have come into use, so studies have been done to compare these new techniques to the gold standard TURP technique. The aim of this study was to compare the results of TURP, holmium laser enucleation of the prostate (HoLEP), and radiofrequency ablation (RFA) in men. Materials and methods: The patients who had the TURP procedure were defined as group 1 (G1), those who had HoLEP were in group 2 (G2), and those who had RFA were in group 3 (G3). Preoperative and postoperative results were compared, with postoperative checks done at 1, 12, 24, and 36 months. Results: There were 41, 40, and 40 patients in G1, G2, and G3, respectively. The mean ages for G1, G2, and G3 were 68.21 ± 8.19, 65.44 ± 10.48, and 77.32 ± 10.58, respectively. The decrease in international prostate symptom score (IPSS) was similar in G1 and G2 for all follow-up periods, but the decrease for G3 was smaller. The quality of life improvement can be summarized as G1 > G2 > G3 at the 36-month follow-up. Scores on the overactive bladder questionnaire (OAB-V8) decreased at the 1-month follow-up for G1 and G2, but then started to increase again over time. Scores on the international index of erectile function (IIEF-5) improved in a continuous fashion up to the 36 Conclusions: The TURP and HoLEP procedures yielded equal improvement in IPSS, however HoLEP had a higher incontinence rate. RFA did not yield much improvement in IPSS, however it seems suitable for older patients with the lowest incontinence rates. None of the techniques provided an improvement in terms of the OAB-V8.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.